Liminatus Pharma, Inc. (LIMN)

0.23 -0.01 (-2.79%) USD  |  NASDAQ  |  Feb 24, 16:00
0.2335 0.00 (0.00%) After-Hours: 20:00
More

Liminatus Pharma Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
CDT Equity, Inc. Upgrade
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade